NOT-HL-16-462: Notice of Availability of Frequently Asked Questions for RFA-HL-17-009 Clinical Centers for the NHLBIs Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) Network (UG1)

Notice of Availability of Frequently Asked Questions for RFA-HL-17-009 Clinical Centers for the NHLBI’s Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) Network (UG1)

Notice Number: NOT-HL-16-462

Key Dates
Release Date: November 3, 2016

Related Announcements
NOT-HL-16-459
RFA-HL-17-009

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding applications for RFA-HL-17-009 Clinical Centers for the NHLBI’s Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) Network (UG1) .

The FAQs are available at this site:
https://www.nhlbi.nih.gov/research/funding/faq-rfa-hl-17-009-clinical-centers-nhlbi%E2%80%99s-precision-interventions-severe-andor-exacerbation-prone

All applicants are encouraged to view the FAQs prior to submitting their application.

Inquiries

Please direct all inquiries to:

Patricia Noel, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0202
Email: noelp@nih.gov